Schindellegi - Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the company from the Greater Zurich Area has started producing prototypes. Further clinical trials will now follow.

The start-up company Zynnon from Schindellegi in the canton of Schwyz is working on a non-invasive technology for diagnosing viral respiratory infections. It is designed to enable the rapid diagnosis of respiratory diseases, particularly in hospitals and care facilities. This could help improve treatment and prevent the unnecessary administration of antibiotics.

According to a statement, Zynnon has now reached a new milestone in the development of the technology. Following several successful studies, the company has started producing prototypes. These will now be tested as part of larger clinical trials.

Khaled Abousaleh, CEO of Zynnon, said the achievement was supported by partners. In the statement, he highlights the CSEM research center, the La Source School of Nursing in Lausanne, and the Swiss Innovation Agency Innosuisse. ce/ssp

Related news

Meet with an expansion expert

Our services are free of charge and include:

  • Introduction to key contacts in industry, academia, and government
  • Advice on regulatory framework, taxes, labor, market, and setting up a company
  • Custom-made fact-finding visits, including office and co-working space